Opinercept
- Generic Name
- Opinercept
A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Mycenax Biotech Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT01709760
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
🇨🇳Changhua Christian Hospital, Changhua, Taiwan
🇨🇳Buddhist Tzu Chi General Hospital, Chiayi City, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath